Ultimately, we adopted identical chemogenetic and optogenetic approaches to manipulate GABAergic BNSTAV-PVN neurons in a cohort of Vgat-Cre mice with a history of MS. This evidence concerns the gene SLC32A1 and myeloid sarcoma.